Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 20, Issue 9, Pages 15910-15928
Publisher
MDPI AG
Online
2015-09-01
DOI
10.3390/molecules200915910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is More Not Better?
- (2015) Emily K. Bergsland HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
- (2015) Arpita Datta et al. Oncotarget
- A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
- (2014) Zhenfeng Duan et al. BMC CANCER
- RETRACTED ARTICLE: Suppression of the xCT–CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin
- (2014) Feng Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
- (2014) Fiona Tan et al. CURRENT DRUG TARGETS
- Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells
- (2014) Haifa Rahabi-Layachi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Role of Lipolysis Stimulated Lipoprotein Receptor in Breast Cancer and Directing Breast Cancer Cell Behavior
- (2014) Denise K. Reaves et al. PLoS One
- The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
- (2014) W Wei et al. Cell Death & Disease
- Oncology Drug Discovery: Planning a Turnaround
- (2014) C. Toniatti et al. Cancer Discovery
- Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension
- (2013) John J.B. Anderson Annals of the New York Academy of Sciences
- Application of Calcium Phosphate as a Controlled-Release Device
- (2013) Tomoko Ito et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Effects of Extracellular Phosphate on Gene Expression in Murine Osteoblasts
- (2013) C. Rendenbach et al. CALCIFIED TISSUE INTERNATIONAL
- Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)
- (2013) Silvio Naviglio et al. CURRENT PHARMACEUTICAL DESIGN
- Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
- (2013) Annamaria Spina et al. CURRENT PHARMACEUTICAL DESIGN
- Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis
- (2013) Hongbo Wang et al. Evidence-based Complementary and Alternative Medicine
- Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells
- (2013) Silvio Naviglio Frontiers in Bioscience-Landmark
- Recent Advances of Calcium Phosphate Nanoparticles for Controlled Drug Delivery
- (2013) Wu Jun et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- STAT signaling in mammary gland differentiation, cell survival and tumorigenesis
- (2013) S. Haricharan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells
- (2013) ANNAMARIA SPINA et al. ONCOLOGY REPORTS
- Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
- (2013) Liang Huang et al. World Journal of Surgical Oncology
- Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation
- (2012) R F Cox et al. BRITISH JOURNAL OF CANCER
- Phosphate as a sensor and signaling molecule
- (2012) Yves Sabbagh CLINICAL NEPHROLOGY
- Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity
- (2012) Dorota W. Kulesza et al. EXPERIMENTAL CELL RESEARCH
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway
- (2012) Annamaria Spina et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress
- (2012) Andrea R Tentner et al. Molecular Systems Biology
- Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
- (2012) Ibrahim Tekedereli et al. PLoS One
- XZH-5 Inhibits STAT3 Phosphorylation and Enhances the Cytotoxicity of Chemotherapeutic Drugs in Human Breast and Pancreatic Cancer Cells
- (2012) Aiguo Liu et al. PLoS One
- Inorganic phosphate stimulates apoptosis in murine MO6-G3 odontoblast-like cells
- (2011) A. Bourgine et al. ARCHIVES OF ORAL BIOLOGY
- Metastatic Triple-negative Breast Cancer
- (2011) E.A. Rakha et al. CLINICAL ONCOLOGY
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells
- (2010) Silvio Naviglio et al. CANCER BIOLOGY & THERAPY
- Triple-Negative Breast Cancer
- (2010) Steven J. Isakoff CANCER JOURNAL
- Elevated Phosphate Activates N-ras and Promotes Cell Transformation and Skin Tumorigenesis
- (2010) C. E. Camalier et al. Cancer Prevention Research
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals
- (2010) Solmaz Khoshniat et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Emerging Targeted Therapies for Breast Cancer
- (2010) Ricardo H. Alvarez et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment options for patients with triple-negative breast cancer
- (2010) Rafael Santana-Davila et al. Journal of Hematology & Oncology
- Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
- (2009) M.-Y. Wang et al. CANCER RESEARCH
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Next generation oncology drug development: opportunities and challenges
- (2009) Martin E. Gutierrez et al. Nature Reviews Clinical Oncology
- Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response
- (2008) Sophie Vibet et al. FREE RADICAL BIOLOGY AND MEDICINE
- Overexpression of the dual specificity phosphatase, Cdc25C, confers sensitivity on tumor cells to doxorubicin-induced cell death
- (2008) S. Varmeh et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now